This act establishes new labeling requirements and clarifies regulatory oversight for cell-cultivated protein products and plant-based alternative protein products under the USDA and FDA.
Pete Ricketts
Senator
NE
The FAIR Labels Act of 2026 establishes clear labeling requirements and regulatory oversight for both cell-cultivated protein products and plant-based alternative protein products. It mandates that cell-cultivated products must prominently feature the term "cell-cultivated" on their labels, while plant-based alternatives must be clearly identified as "plant-based alternative protein product." Furthermore, the bill updates the agreement between the USDA and HHS to clarify their respective roles in regulating the safety and production of cell-cultivated protein.
Ever stared at a new food product in the grocery store, wondering exactly what it is? The new Fair and Accurate Ingredient Representation on Labels Act of 2026, or FAIR Labels Act, is stepping in to clear things up, especially for those newer cell-cultivated and plant-based protein options. This bill sets out to make sure you know exactly what you’re putting in your shopping cart by requiring clear, specific labels and defining who regulates these products.
One of the first things this bill tackles is clarifying the regulatory turf. Right now, when you’re talking about food made from animal cells grown outside an animal, it can get a bit murky. This Act, under Section 2, updates a 2019 agreement between the U.S. Department of Agriculture (USDA) and the Food and Drug Administration (FDA). Essentially, the FDA will now be in charge of the early stages of cell-cultivated protein production—think tissue collection, cell banks, and ensuring manufacturing controls are up to snuff. They’ll also handle inspections for these initial steps. Once those cells are harvested, the USDA steps in to oversee the rest, treating these products much like traditional meat and poultry. This division aims to create a clearer path for these new foods to get to market, ensuring safety checks at every stage.
Now, for the part that hits your shopping cart directly: the labels. Section 3 of the FAIR Labels Act gets very specific about how these products must be identified. If you’re looking at a cell-cultivated protein product—that’s anything made from animal cells or DNA grown outside a live animal—its label will have to scream “cell-cultivated” right next to the food’s name. Plus, it’ll need a disclaimer making it clear that it’s not traditional meat from a live animal. No more guessing games there.
For plant-based alternative protein products—those veggie burgers and chicken-less nuggets designed to look and taste like meat or poultry—the rules are similar. Their labels will need to prominently feature “plant-based alternative protein product” followed by the food’s name, along with a clear statement that it’s not derived from a live animal or bird. The idea is to make sure that whether you’re a lifelong vegan or a meat-and-potatoes person, you can tell at a glance what you’re buying.
The bill also gives the USDA a tight deadline: within 180 days, it needs to establish official “standards of identity” for both cell-cultivated and plant-based protein products, working with the FDA. Think of these as the official rulebooks that define exactly what these products are. This move could bring more consistency to the market, but it also means companies producing these novel foods will need to adapt to these new, potentially strict, guidelines. For smaller producers, especially those innovating in this space, keeping up with new regulations and labeling requirements could mean extra costs and administrative hurdles. While the goal is transparency for you, the consumer, the path to getting these labels just right could be a bit bumpy for the folks making these foods.